Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$40.47

-0.25 (-0.61%)

17:27
12/10/18
12/10
17:27
12/10/18
17:27

Biohaven Pharmaceutical files to sell 3M shares of common stock

BHVN Biohaven Pharmaceutical
$40.47

-0.25 (-0.61%)

12/10/18
PIPR
12/10/18
NO CHANGE
Target $65
PIPR
Overweight
Biohaven's rimegepant 'definitively' safe, well tolerated, says Piper Jaffray
Biohaven Pharmaceutical this morning reported positive data from a 12-month safety study of 1,780 patients, which included regularly scheduled liver function tests, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. The bottom line is that rimegepant now definitively appears to be a safe and well-tolerated treatment and that Biohaven has successfully engineered out the liver toxicity associated with the first generation oral calcitonin gene-related peptides, says the analyst. He adds rimegepant also demonstrated efficacy in prevention, which he thinks bodes well for the ongoing pivotal trial. Van Buren reiterates an Overweight rating on Biohaven Pharmaceutical with a $65 price target.
12/03/18
PIPR
12/03/18
NO CHANGE
Target $65
PIPR
Overweight
Piper says buy Biohaven 'aggressively' after 'impressive' data
Biohaven Pharmaceutical (BHVN) this morning reported "impressive" topline data from the Phase III trial testing the Zydis orally dissolving tablet formulation of rimegepant, Piper Jaffray analyst Tyler Van Buren tells investors in a research note. The study not only achieved statistical significance on both co-primary endpoints, "but surprisingly" also demonstrated an "incredibly rapid" 15 minute onset of action, says the analyst. Further, he notes that Biohaven reported pooled safety data from what is now three Phase III rimegepant studies and that the candidate "continues to be safe and well tolerated" with no signal of liver toxicity. Van Buren believes the new data "definitely makes" rimegepant a superior product to Allergan's (AGN) ubrogepant and the "best-in-class" oral calcitonin gene-related peptide. He reiterates an Overweight rating on Biohaven with a $65 price target and recommends that investors buy the stock "aggressively."
11/29/18
PIPR
11/29/18
NO CHANGE
PIPR
Piper Jaffray says 'no good reason' for Biohaven pullback
Piper Jaffray analyst Tyler Van Buren reiterated an Overweight rating on Biohaven after attending the company's R&D day and hosting a fireside chat and investor dinner with company management during the 30th Annual Piper Jaffray Healthcare Conference. The analyst noted that Biohaven shares have experienced a significant pullback, for which he believes there was "no good fundamental reason." Van Buren added that after this week, he has an even higher level on conviction in a "clean 12-month safety update and a successful Phase III ODT study... and therefore rimegepant's $1B+ potential."
11/27/18
CANT
11/27/18
NO CHANGE
Target $55
CANT
Overweight
Cantor reiterates $55 price target on Biohaven after R&D day
Cantor Fitzgerald analyst Charles Duncan reiterates an Overweight rating on Biohaven Pharmaceutical with a $55 price target after attending the company's R&D day. The event was an opportunity to see the breadth of the company's glutamate pipeline, which "is notably broad, but early," Duncan tells investors in a research note. The analyst sees investor focus shifting toward troriluzole and the glutamate platform pending "interpretable, positive data" out of ongoing clinical trials in two indications in 2019.

TODAY'S FREE FLY STORIES

OSMT

Osmotica Pharmaceuticals

$4.00

-0.03 (-0.74%)

16:23
11/14/19
11/14
16:23
11/14/19
16:23
Earnings
Osmotica Pharmaceuticals reports Q3 EPS ($2.15), consensus (23c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BOX

Box

$15.82

-0.38 (-2.35%)

, CARS

Cars.com

$12.56

0.48 (3.97%)

16:22
11/14/19
11/14
16:22
11/14/19
16:22
Hot Stocks
Starboard adds 7M shares of Box in Q3, exits Cars.com and Dollar Tree »

Jeffrey Smith's…

BOX

Box

$15.82

-0.38 (-2.35%)

CARS

Cars.com

$12.56

0.48 (3.97%)

DLTR

Dollar Tree

$108.71

0.305 (0.28%)

MRVL

Marvell

$26.98

-1.13 (-4.02%)

NTUS

Natus Medical

$31.54

-0.56 (-1.74%)

KAR

KAR Auction

$22.80

0.88 (4.01%)

NLOK

NortonLifeLock

$24.52

-0.05 (-0.20%)

ACM

Aecom

$43.49

1.275 (3.02%)

CERN

Cerner

$67.03

0.25 (0.37%)

PRGO

Perrigo

$48.03

-0.385 (-0.80%)

AAP

Advance Auto Parts

$156.93

-1.52 (-0.96%)

RPM

RPM

$74.62

0.915 (1.24%)

EBAY

eBay

$34.95

0.3 (0.87%)

SCOR

comScore

$3.98

(0.00%)

IWN

iShares Russell 2000 Value Index

$124.16

-0.03 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 26

    Nov

  • 03

    Dec

  • 04

    Dec

  • 09

    Dec

  • 06

    Jan

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:22
11/14/19
11/14
16:22
11/14/19
16:22
Hot Stocks
Nvidia to return to stock buybacks after closing Mellanox deal in early FY20 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:21
11/14/19
11/14
16:21
11/14/19
16:21
Hot Stocks
Nvidia CEO says gaming business and hyperscale demand powered Q3 results »

CEO Jensen Huang says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

UVE

Universal Insurance

$30.07

-0.43 (-1.41%)

16:21
11/14/19
11/14
16:21
11/14/19
16:21
Hot Stocks
Universal Insurance declares regular, special cash dividend »

Universal Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRE

Aprea Therapeutics

$26.92

2.45 (10.01%)

16:20
11/14/19
11/14
16:20
11/14/19
16:20
Earnings
Aprea Therapeutics reports Q3 EPS ($5.29), consensus ($3.94) »

As of September 30, prior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:20
11/14/19
11/14
16:20
11/14/19
16:20
Earnings
Nvidia reports Q3 adjusted EPS $1.78, consensus $1.57 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/14/19
11/14
16:20
11/14/19
16:20
Options
Closing CBOE SPX and VIX Index summary for November 14th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$175.21

2 (1.15%)

16:19
11/14/19
11/14
16:19
11/14/19
16:19
Hot Stocks
Breaking Hot Stocks news story on RH »

RH up 7% in afterhours…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLB

Dolby

$65.56

-0.14 (-0.21%)

16:19
11/14/19
11/14
16:19
11/14/19
16:19
Earnings
Dolby sees FY20 adjusted EPS $3.40-$3.50, consensus $2.87 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

CSSE

Chicken Soup for the Soul

$9.99

0.28 (2.88%)

16:19
11/14/19
11/14
16:19
11/14/19
16:19
Earnings
Chicken Soup for the Soul reports Q3 adjusted EPS ($1.03), consensus (5c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DLB

Dolby

$65.56

-0.14 (-0.21%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Earnings
Dolby sees Q1 adjusted EPS 45c-51c, consensus 65c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

CY

Cypress Semiconductor

$23.43

0.01 (0.04%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Downgrade
Cypress Semiconductor rating change  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$91.26

-0.02 (-0.02%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Hot Stocks
Nike raises quarterly dividend to 24.5c from 22c per share »

The dividend declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$109.21

4.195 (3.99%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Earnings
Globant raises FY19 non-IFRS EPS view to $2.23-$2.27 from $2.19-$2.25 »

Consensus $2.24. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/14/19
11/14
16:17
11/14/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSN

Celsion

$1.38

0.29 (26.73%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Celsion reports Q3 EPS (25c), consensus (28c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

HAYN

Haynes

$35.83

-0.31 (-0.86%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Haynes reports Q4 EPS 48c, consensus 40c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

DLB

Dolby

$65.56

-0.14 (-0.21%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Dolby reports Q4 adjusted EPS 66c, consensus 48c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

GLOB

Globant

$109.21

4.195 (3.99%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Globant sees Q4 non-IFRS adjusted EPS 58c-62c, consensus 63c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GIFI

Gulf Island Fabrication

$4.38

0.07 (1.62%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Hot Stocks
Gulf Island Fabrication board Chairman Jack Laborde to step down »

Gulf Island Fabrication…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$109.21

4.195 (3.99%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Earnings
Globant reports Q3 non-IFRS EPS 62c, consensus 59c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
11/14/19
11/14
16:16
11/14/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$175.21

2 (1.15%)

, BRK.A

Berkshire Hathaway

$329,095.00

-505 (-0.15%)

16:15
11/14/19
11/14
16:15
11/14/19
16:15
Hot Stocks
Warren Buffet's Berkshire Hathaway takes stake in RH »

The stake in RH was…

RH

RH

$175.21

2 (1.15%)

BRK.A

Berkshire Hathaway

$329,095.00

-505 (-0.15%)

BRK.B

Berkshire Hathaway

$219.42

-0.39 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:15
11/14/19
11/14
16:15
11/14/19
16:15
General news
Breaking General news story  »

Week of 11/4 Money Supply…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.